First patients receive new 'T-Cell Engager' drug in early cancer trial
Disease control
Recruiting now
This is the first time a new drug called CDR404 is being tested in people. It is designed for adults with advanced solid tumors that have a specific protein called MAGE-A4 and a specific genetic marker (HLA-A*02:01). The main goals are to find a safe dose and see if the drug show…
Phase: PHASE1 • Sponsor: CDR-Life AG • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC